Hydralazine and sodium nitroprusside have been used to identify neurons activated
by lowering blood pressure. Such hypotensive stimuli can however evoke hyperglycemia.
The aim was to identify the neurochemistry and identity of cells activated in the
spinal cord and adrenal medulla in response to hydralazine. Multilabel immunoreactivity
(ir) in combination with in situ hybridization was used to identify activated cells and their neurochemistry following
10 mg/kg i.p. hydralazine (HDZ) or saline. 16 ± 0.1% (n = 3) of ChAT-ir sympathetic preganglionic neurons (SPN) contained c-Fos-ir following
HDZ whereas following saline no SPN were activated. Blood glucose levels were 23.8 ± 2.8 mmol/L (HDZ, n = 7) and 10.6 ± 0.8 mmol/L (saline, n = 7 p < 0.001) whereas plasma adrenaline levels were similar between the two conditions (0.4 ± 0.2 ng/ml; n = 7 and 0.5 ± 0.1 ng/ml; n = 7) and plasma noradrenaline levels were increased following HDZ (1.3 ± 0.3 ng/ml; n = 5; vs saline 0.4 ± 0.1 ng/ml; n = 5 p < 0.01). 62.8 ± 1.4% of SPN projecting to the adrenal gland (n = 3) and 53.2 ± 8.6% of SPN projecting to the celiac ganglia (n = 3) contained c-Fos-ir after HDZ injection. Of activated SPN that projected to the
adrenal gland 29.9 ± 3.3% and 31.2 ± 8.8% of activated SPN that projected to the celiac ganglia expressed PPE mRNA. We
have previously demonstrated that 100% of adrenally projecting SPN that expressed
PPE mRNA were activated by a glucoprivic stimulus that activated adrenaline but not
noradrenaline releasing chromaffin cells (Parker et al 2013). Together these results
indicate that SPN activated by blood pressure lowering stimuli include those that
innervate adrenaline releasing chromaffin cells. However HDZ did not evoke c-Fos -ir
in adrenal chromaffin cells nor did it phosphorylate serine residues of the tyrosine
hydroxylase enzyme in the adrenal medulla which increase enzyme activity or plasma
adrenaline. Thus HDZ did not activate the adrenal medulla despite the fact that adrenally
projecting SPN were activated.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Autonomic Neuroscience: Basic and ClinicalAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
Received:
May 15,
2013
Identification
Copyright
© 2013 Published by Elsevier Inc.